OncoSil Medical Limited
ASX: OSL.AX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Australian Securities Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Nigel Lange
- Employees
- 2
- Headquarters
- Macquarie Park, Australia
- IPO year
- 2005
- Market cap
- A$9.6M
- Website
- https://www.oncosil.com.au
Loading OSL…
Loading profile data…Frequently asked questions about OSL
What does OncoSil Medical Limited (OSL.AX) do?
OncoSil Medical Limited, a medical device company, focuses on the development and commercialization of localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma in worldwide. Its lead product is OncoSil, a brachytherapy device indicated for the treatment of patients with locally advanced unresectable pancreatic ca...
Where does OSL.AX trade?
OncoSil Medical Limited (OSL.AX) trades on the Australian Securities Exchange.
What sector is OSL.AX in?
OncoSil Medical Limited (OSL.AX) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of OncoSil Medical Limited?
Nigel Lange is the chief executive officer of OncoSil Medical Limited (OSL.AX).
Where is OncoSil Medical Limited headquartered?
OncoSil Medical Limited is headquartered in Australia.
Does OSL.AX pay a dividend?
OncoSil Medical Limited (OSL.AX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did OSL.AX go public?
OncoSil Medical Limited (OSL.AX) completed its initial public offering in 2005.